| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $37.2M | +22.7% |
| SG&A Expense | $13.5M | +2.3% |
| Operating Income | -$50.7M | -16.5% |
| Income Tax | $0 | — |
| Net Income | -$25.8M | -20.5% |
| EPS (Basic) | -$0.86 | +5.5% |
| EPS (Diluted) | -$0.86 | +5.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $29.9M | -28.0% |
| Current Assets | $34.2M | -28.2% |
| Total Assets | $35.2M | -30.3% |
| Current Liabilities | $10.2M | +30.5% |
| Total Liabilities | $10.7M | +5.0% |
| Stockholders' Equity | $24.5M | -39.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$16.0M | +13.6% |
| Capital Expenditures | $147K | -14.0% |
| Investing Cash Flow | -$147K | +14.0% |
| Financing Cash Flow | $4.5M | -18.5% |
| Free Cash Flow | -$16.2M | +13.6% |